Migraine Study in Adolescent Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

589

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

June 30, 2010

Conditions
Migraine Disorders
Interventions
DRUG

Sumatriptan and Naproxen Sodium

Sumatriptan succinate and naproxen sodium

DRUG

Placebo

Placebo to match

Trial Locations (79)

10550

GSK Investigational Site, Mount Vernon

11501

GSK Investigational Site, Mineola

12308

GSK Investigational Site, Schenectady

14226

GSK Investigational Site, Amherst

15236

GSK Investigational Site, Pittsburgh

19139

GSK Investigational Site, Philadelphia

21208

GSK Investigational Site, Pikesville

22902

GSK Investigational Site, Charlottesville

23510

GSK Investigational Site, Norfolk

27607

GSK Investigational Site, Raleigh

29651

GSK Investigational Site, Greer

29681

GSK Investigational Site, Simpsonville

30281

GSK Investigational Site, Stockbridge

30342

GSK Investigational Site, Atlanta

31405

GSK Investigational Site, Savannah

32504

GSK Investigational Site, Pensacola

32607

GSK Investigational Site, Gainesville

33010

GSK Investigational Site, Hialeah

33407

GSK Investigational Site, West Palm Beach

37043

GSK Investigational Site, Clarksville

37620

GSK Investigational Site, Bristol

40004

GSK Investigational Site, Bardstown

40509

GSK Investigational Site, Lexington

43081

GSK Investigational Site, Westerville

44195

GSK Investigational Site, Cleveland

45069

GSK Investigational Site, West Chester

45229

GSK Investigational Site, Cincinnati

45245

GSK Investigational Site, Cincinnati

46011

GSK Investigational Site, Anderson

47802

GSK Investigational Site, Terre Haute

48104

GSK Investigational Site, Ann Arbor

53715

GSK Investigational Site, Madison

55441

GSK Investigational Site, Plymouth

60068

GSK Investigational Site, Park Ridge

60453

GSK Investigational Site, Oak Lawn

60642

GSK Investigational Site, Chicago

63141

GSK Investigational Site, St Louis

65807

GSK Investigational Site, Springfield

66160

GSK Investigational Site, Kansas City

67207

GSK Investigational Site, Wichita

68130

GSK Investigational Site, Omaha

72034

GSK Investigational Site, Conway

72202

GSK Investigational Site, Little Rock

72205

GSK Investigational Site, Little Rock

73112

GSK Investigational Site, Oklahoma City

75230

GSK Investigational Site, Dallas

78258

GSK Investigational Site, San Antonio

80907

GSK Investigational Site, Colorado Springs

84107

GSK Investigational Site, Salt Lake City

85013

GSK Investigational Site, Phoenix

85014

GSK Investigational Site, Phoenix

85016

GSK Investigational Site, Phoenix

85234

GSK Investigational Site, Gilbert

85340

GSK Investigational Site, Litchfield Park

87108

GSK Investigational Site, Albuquerque

89014

GSK Investigational Site, Henderson

90404

GSK Investigational Site, Santa Monica

92647

GSK Investigational Site, Huntington Beach

92660

GSK Investigational Site, Newport Beach

92835

GSK Investigational Site, Fullteron

93720

GSK Investigational Site, Fresno

94109

GSK Investigational Site, San Francisco

95678

GSK Investigational Site, Roseville

95815

GSK Investigational Site, Sacramento

95816

GSK Investigational Site, Sacramento

95926

GSK Investigational Site, Chico

97210

GSK Investigational Site, Portland

97301

GSK Investigational Site, Salem

97401

GSK Investigational Site, Eugene

98686

GSK Investigational Site, Vancouver

98801

GSK Investigational Site, Wenatchee

06824

GSK Investigational Site, Fairfield

33155-3009

GSK Investigational Site, Miami

01605

GSK Investigational Site, Worcester

08043

GSK Investigational Site, Vorhees

08046

GSK Investigational Site, Willingboro

77030-2303

GSK Investigational Site, Houston

98195-6097

GSK Investigational Site, Seattle

53562-2215

GSK Investigational Site, Middleton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY